Carl E. Clay
Impact in
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
- NF-κB Signaling Pathways
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Inflammatory mediators and NSAID effects 8
-
- Peroxisome Proliferator-Activated Receptors 7
- Co-authors
- Kevin P. High (7 shared papers)Floyd H. Chilton (7 shared papers)Gen‐ichi Atsumi (4 shared papers)Alfred N. Fonteh (4 shared papers)Andrew M. Namen (3 shared papers)Anthony J. Trimboli (3 shared papers)Mark C. Willingham (3 shared papers)Arta M. Monjazeb (2 shared papers)
- Journals
- Journal of Lipid Research (1 paper)Prostaglandins Leukotrienes and Essential Fatty Acids (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)Carcinogenesis (1 paper)Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (1 paper)
- Partner nations
- United StatesJapanRussia
In The Last Decade
Carl E. Clay
11 papers receiving 531 citations
Peers
Comparison fields: 5 of 66
- Cancer Research 164
- Biochemistry 85
- Pharmacology 168
- Molecular Biology 378
- Nutrition and Dietetics 59
Countries citing papers authored by Carl E. Clay
This map shows the geographic impact of Carl E. Clay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl E. Clay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl E. Clay more than expected).
Fields of papers citing papers by Carl E. Clay
This network shows the impact of papers produced by Carl E. Clay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl E. Clay. The network helps show where Carl E. Clay may publish in the future.
Co-authors
The 25 scholars most cited alongside Carl E. Clay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 162 | |
| 2 | 2002 | 92 | |
| 3 | 2001 | 61 | |
| 4 | 2005 | 59 | |
| 5 | 2001 | 58 | |
| 6 | 2006 | 52 | |
| 7 | Influence of coenzyme A-independent transacylase and cyclooxygenase inhibitors on the proliferation of breast cancer cells. | 1999 | 31 |
| 8 | 2002 | 15 | |
| 9 | 1998 | 12 | |
| 10 | 2004 | 5 | |
| 11 | 1999 | 1 |
About Carl E. Clay
Carl E. Clay is a scholar working on Pharmacology, Molecular Biology, Biochemistry, Cancer Research and Organic Chemistry, having authored 11 papers that have together received 548 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (8 papers), Peroxisome Proliferator-Activated Receptors (7 papers), Eicosanoids and Hypertension Pharmacology (5 papers), Cancer, Lipids, and Metabolism (3 papers), Drug Transport and Resistance Mechanisms (1 paper), Alcohol Consumption and Health Effects (1 paper), NF-κB Signaling Pathways (1 paper) and Adipose Tissue and Metabolism (1 paper). The work is most often cited by research in Cancer Research (164 citations), Biochemistry (85 citations), Pharmacology (168 citations), Molecular Biology (378 citations) and Nutrition and Dietetics (59 citations). Carl E. Clay has collaborated with scholars based in United States, Japan and Russia. Frequent co-authors include Kevin P. High, Floyd H. Chilton, Gen‐ichi Atsumi, Alfred N. Fonteh, Andrew M. Namen, Anthony J. Trimboli, Mark C. Willingham, Arta M. Monjazeb, Timothy E. Kute and Jacqueline Thorburn. Their work appears in journals such as Journal of Lipid Research, Prostaglandins Leukotrienes and Essential Fatty Acids, Journal of Pharmacology and Experimental Therapeutics, Carcinogenesis and Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.